ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China · Delayed Price · Currency is CNY 9.31
-0.31 (-3.22%)
Jun 11, 2026, 3:04 PM CST
SHE:300254 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,463 | 2,592 | 2,173 | 2,327 | 1,636 | 1,981 | |
Market Cap Growth | 9.61% | 19.29% | -6.62% | 42.24% | -17.43% | 26.13% |
Enterprise Value | 2,971 | 3,272 | 2,352 | 2,579 | 1,773 | 2,248 |
Last Close Price | 9.62 | 10.12 | 8.75 | 9.63 | 6.77 | 8.69 |
PE Ratio | 132.87 | 104.30 | 51.50 | 92.35 | - | - |
Forward PE | - | 47.48 | 47.48 | 47.48 | 47.48 | 47.48 |
PS Ratio | 2.85 | 2.98 | 2.57 | 2.91 | 1.97 | 2.13 |
PB Ratio | 4.79 | 4.36 | 3.63 | 2.99 | 2.24 | 2.66 |
P/TBV Ratio | - | - | - | 25.93 | 32.48 | 68.49 |
P/FCF Ratio | 30.93 | 41.50 | 111.77 | 596.91 | 34.01 | 33.02 |
P/OCF Ratio | 21.85 | 26.78 | 30.63 | 61.53 | 21.85 | 20.44 |
EV/Sales Ratio | 3.44 | 3.76 | 2.78 | 3.23 | 2.14 | 2.42 |
EV/EBITDA Ratio | 18.32 | 20.44 | 18.88 | 30.48 | 51.17 | 63.24 |
EV/EBIT Ratio | 28.60 | 30.00 | 32.20 | 80.55 | - | - |
EV/FCF Ratio | 37.31 | 52.39 | 120.98 | 661.62 | 36.87 | 37.47 |
Debt / Equity Ratio | 1.11 | 0.68 | 0.76 | 0.29 | 0.40 | 0.31 |
Debt / EBITDA Ratio | 3.53 | 2.40 | 3.48 | 2.50 | 7.02 | 5.92 |
Debt / FCF Ratio | 7.18 | 6.43 | 23.50 | 58.03 | 6.01 | 3.83 |
Net Debt / Equity Ratio | 0.84 | 0.40 | 0.51 | 0.12 | 0.03 | 0.16 |
Net Debt / EBITDA Ratio | 2.81 | 1.50 | 2.47 | 1.11 | 0.72 | 3.44 |
Net Debt / FCF Ratio | 5.45 | 3.85 | 15.81 | 24.17 | 0.52 | 2.04 |
Asset Turnover | 0.56 | 0.55 | 0.57 | 0.53 | 0.53 | 0.56 |
Inventory Turnover | 1.95 | 2.15 | 2.23 | 2.32 | 2.37 | 2.51 |
Quick Ratio | 0.67 | 0.72 | 0.60 | 0.63 | 0.63 | 0.63 |
Current Ratio | 0.99 | 0.98 | 0.88 | 0.96 | 0.85 | 0.94 |
Return on Equity (ROE) | 8.71% | 9.46% | 10.86% | 6.46% | -13.28% | -9.22% |
Return on Assets (ROA) | 4.23% | 4.27% | 3.06% | 1.33% | -0.95% | -1.06% |
Return on Invested Capital (ROIC) | 6.43% | 7.79% | 7.62% | 3.47% | -2.92% | -3.03% |
Return on Capital Employed (ROCE) | 10.20% | 10.60% | 7.50% | 3.20% | -2.40% | -2.50% |
Earnings Yield | 0.72% | 0.96% | 1.94% | 1.08% | -7.25% | -4.62% |
FCF Yield | 3.23% | 2.41% | 0.90% | 0.17% | 2.94% | 3.03% |
Payout Ratio | 101.63% | 76.33% | 29.20% | 52.84% | - | - |
Buyback Yield / Dilution | -1.40% | -1.15% | -0.20% | -1.89% | -4.00% | -6.92% |
Total Shareholder Return | -1.40% | -1.15% | -0.20% | -1.89% | -4.00% | -6.92% |